home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
CULLINAN ONCOLOGY PROVIDES CORPORATE UPDATE AND REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS
CULLINAN ONCOLOGY PROVIDES CORPORATE UPDATE AND REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS
Post navigation
Previous Post
Previous
PMV Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Highlights
Next Post
Next
Boundless Bio Announces $100 Million Oversubscribed Series C Financing co-led by Leaps by Bayer and RA Capital Management to Advance the First ecDNA-Directed Therapies (ecDTx) for Patients with Oncogene Amplified Cancer